These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 13739036)
21. [Characterization of protection mechanisms in patients with drug-resistant pulmonary tuberculosis]. Maliev BM; Selitskaia RP; Gracheva mP; Beliaev DL; Kalinina MB; Mozhokina GN; Babaiants AA; Dorzhiev AB Probl Tuberk Bolezn Legk; 2005; (6):33-5. PubMed ID: 16078719 [TBL] [Abstract][Full Text] [Related]
22. [Fibrinolytic acitivity of plasma in pulmonary tuberculosis]. Boccitto G; Frisani G; Salvati F; Sternini M Ann Ist Carlo Forlanini; 1967; 27(4):362-76. PubMed ID: 5607095 [No Abstract] [Full Text] [Related]
23. [Effect of blood loss on the morphological and protein composition of the blood in patients with pulmonary tuberculosis]. Kolesnik IP; Gontsova IuV Vrach Delo; 1968 Jul; 7():57-60. PubMed ID: 5744396 [No Abstract] [Full Text] [Related]
24. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test]. Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812 [TBL] [Abstract][Full Text] [Related]
25. Changes in serum selenium, copper, zinc levels and cu/zn ratio in patients with pulmonary tuberculosis during therapy. Ciftci TU; Ciftci B; Yis O; Guney Y; Bilgihan A; Ogretensoy M Biol Trace Elem Res; 2003 Oct; 95(1):65-71. PubMed ID: 14555800 [TBL] [Abstract][Full Text] [Related]
26. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis]. Novozhilova IA Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041 [No Abstract] [Full Text] [Related]
27. The early bactericidal activity of anti-tuberculosis drugs: a literature review. Donald PR; Diacon AH Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155 [TBL] [Abstract][Full Text] [Related]
28. [Cytokine-producing activity of peripheral mononuclear leukocytes in patients with pulmonary tuberculosis before and during chemotherapy]. Novitskiĭ VV; Sinitsyna VA; Voronkova OV; Strelis AK; Urazova OI; Filiniuk OV; Zemlianaia NA; Luk'ianova TA; Esimova IE Probl Tuberk Bolezn Legk; 2005; (6):39-42. PubMed ID: 16078721 [TBL] [Abstract][Full Text] [Related]
29. [The specific features of a pathogen in acutely progressive pulmonary tuberculosis]. Balasaniants GS; Greĭmer MS Probl Tuberk Bolezn Legk; 2003; (9):29-31. PubMed ID: 14598524 [TBL] [Abstract][Full Text] [Related]
30. [Occurence of primary resistance in hospital patients with respiratory tuberculosis]. Serdarević H; Bogdanović M; Travnik H; Simeonov L Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090 [No Abstract] [Full Text] [Related]
31. Initial drug resistance pattern in new cases of pulmonary tuberculosis. Chandramuki A; Nagarathna S; Veena Kumari HB; Buggi S J Assoc Physicians India; 2008 Mar; 56():202. PubMed ID: 18697641 [No Abstract] [Full Text] [Related]
32. [Evaluation of the effects of antituberculous drugs on the cytochemical status of lymphocytes in vitro]. Vasil'eva OA; Urazova OI; Serebriakova VA; Novitskiĭ VV; Strelis AK; Shevtsova NM; Voronkova OV; Mel'nik MI; Khasanova RR Probl Tuberk Bolezn Legk; 2008; (3):27-30. PubMed ID: 18450076 [TBL] [Abstract][Full Text] [Related]
33. [Plasma antioxidative activity in patients with pulmonary tuberculosis]. Kowalski J; Janiszewska-Drobińska B; Pawlicki L; Cegliński T; Irzmański R Pol Merkur Lekarski; 2004 Feb; 16(92):119-22. PubMed ID: 15176293 [TBL] [Abstract][Full Text] [Related]
34. [Bacteriological facts that influence the epidemiology of tuberculosis]. Herrera Malmsten L Torax; 1966 Dec; 15(4):240-3. PubMed ID: 5999636 [No Abstract] [Full Text] [Related]